ConvaTec Group: FTSE 100 medical solutions group’s Interims tomorrow will highlight its ongoing growth

Tomorrow morning, Tuesday 29th July, will see the £5.4bn capitalised ConvaTec Group (LON:CTEC) announce its Interim Results for the half-year to end-June, they may not show any surprises, but they should help to showcase the underrating of its shares.
The Business
It was in the 1960’s that Dr James Chen researched masses of formulations that led to the invention of the first hydrocolloid medical adhesive for use in dental surgery, for which it was granted a patent in 1967.
That technology brought about the group’s first product, the Stomahesive® skin barrier, launched after Convatec was founde...

Latest News

More Articles Like This